Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Price, Quote & AI Analysis

Live CRBP stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Corbus Pharmaceuticals Holdings, Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Corbus Pharmaceuticals Holdings, Inc. (CRBP), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

CRBP
Corbus Pharmaceuticals Holdings, Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
7.560000
High
7.670000
Low
7.230000
Volume
101,664
VWAP
-
Market Cap
$130,243,534.54
52W Range
$4.64 - $20.56
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 9, 2026 Q4
After Hours
EPS Estimate: $-1.6657
Revenue Estimate: $1,700,003.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Corbus Pharmaceuticals Holdings, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Corbus Pharmaceuticals Holdings, Inc. Overview

Company information

Company Overview

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.

Company Details
Market Cap
$129.72M
Shares Outstanding
17,553,037
Weighted Shares Outstanding
17,553,037
CEO
Yuval Cohen
Address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Employees
28
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Corbus Pharmaceuticals Holdings, Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...